What does osteopontin do in skin healing and inflammation?

When thinking about scalp health, many of us first consider shampoos, oils, or supplements that nourish hair. Yet beneath the surface, the body depends on complex proteins and molecules that are less visible but far more crucial for repair and protection. Among these is osteopontin, a protein that medical research has studied extensively for its role in wound healing, immune system regulation, and chronic inflammation. To understand scalp healing and inflammation, it is necessary to examine what osteopontin does at the cellular level and how this relates to what we experience.

Osteopontin: More Than a Bone Protein

The name osteopontin might mislead us into assuming it only concerns bones. Initially identified in bone tissue, osteopontin has since been found active in many organs and tissues, including skin. It is a glycoprotein, meaning it is composed of both protein and carbohydrate chains. This structure allows it to interact with receptors on cell surfaces, functioning as a signaling molecule that helps cells communicate during repair processes and immune regulation. In practical terms, osteopontin is not simply structural; it acts as a messenger in how tissues respond to injury.

Our scalps endure constant stress from sunlight, pollution, and even the mechanical pulling that comes from brushing or styling. These stressors can cause micro-damage, small disruptions in the skin barrier that might not be visible but trigger repair responses. A 2014 review describes osteopontin as helping to recruit macrophages, immune cells specialized in clearing debris and dead tissue (Kahles et al., 2014). Whether osteopontin plays a meaningful part in everyday scalp micro-damage has not been studied.

The main animal evidence is a 1998 study by Liaw and colleagues in mice bred to lack osteopontin. Their skin incisions healed with normal strength, but showed less clearing of debris, more disorganised tissue and thinner collagen fibres than in normal mice. This was general skin in mice, not human scalp, so it does not show what happens in our scalps.

Osteopontin and Inflammation

Inflammation is the body’s protective response to injury or irritation. In the scalp, it can manifest as redness, itching, or tenderness, and in chronic cases it may contribute to hair shedding. Osteopontin is usually described as a pro-inflammatory signal. It acts as a cytokine, one of the small proteins that carry messages between immune cells.

A 2014 review by Kahles and colleagues describes osteopontin as a pro-inflammatory cytokine that helps recruit immune cells, and links it with several inflammatory diseases, including inflammation in fat tissue and insulin resistance. The review did not look at skin or scalp, and it does not suggest that osteopontin reduces inflammation.

The Scalp’s Microenvironment and Osteopontin

Unlike other skin surfaces, the scalp is a microenvironment containing hair follicles, sebaceous glands, nerves, and blood vessels. Healing in this region must not only restore the surface barrier but also preserve the structures that maintain hair growth. Osteopontin interacts with integrins, receptors on cell surfaces that coordinate attachment and communication. This interaction allows osteopontin to act as a scaffold protein, both supporting cells physically and transmitting repair signals. A 2000 review by Sodek and colleagues described osteopontin’s dual role in multiple tissues: serving as a structural anchor and a regulator of signaling. This was a review rather than new experimental research, and it did not study the scalp. The limitation of reviews is that they depend on existing studies, but their strength lies in drawing connections between different research areas.

What Do We Need to Know?

Osteopontin takes part in wound repair and inflammation in other tissues, but its role in how the human scalp recovers from stress or irritation has not been studied. The research comes from mouse wounds, reviews and other organs, so it is indirect. In human scalp tissue, the one osteopontin-derived peptide tested (FOL-005) pushed hair follicles toward regression (Alam et al., 2020). No osteopontin product has been shown to help scalp healing, inflammation or hair.

User Experiences

Osteopontin has emerged in the Tressless community as a molecule of interest for scalp healing and inflammation control. Users discussing peptides and novel therapies often link osteopontin to the regenerative environment of the hair follicle. The conversation reflects both excitement and skepticism about its potential in hair loss treatments.

Community discussions show that many users first encountered osteopontin through experimental compounds such as FOL-005, derived from osteopontin. In human scalp tissue, FOL-005 lowered fibroblast growth factor-7 (FGF7) and pushed follicles toward regression (Alam et al., 2020). Some users hope for finasteride-like results without its side effects from a planned cosmetic launch, but there is no published trial showing either; the developer’s own topical trial initially reported no significant benefit over placebo. Others are cautious, pointing out the history of hyped treatments that failed to deliver long-term results.

Several comments highlight that osteopontin’s role may be more complex than simply stimulating growth. Users describe it as a regulator of inflammation and tissue repair, although this has not been studied in the scalp. This dual function raises questions in the community about whether modulating osteopontin might help with conditions beyond androgenetic alopecia, such as alopecia areata or inflammatory scalp disorders. Still, users acknowledge that most of this is theoretical until more robust clinical data become available.

Another theme in community exchanges is delivery methods. Since peptides like osteopontin-derived compounds face challenges penetrating the scalp, people speculate on technologies like iontophoresis, sonophoresis, or microneedling as potential enhancers. This shows a clear link between user curiosity and ongoing bioengineering research, where drug delivery is seen as equally important as the peptide itself. Overall, the community perspective on osteopontin centers on its promise as a scalp-healing, inflammation-modulating factor that might influence hair follicle behavior. However, users remain cautious, emphasizing the need for controlled trials and long-term data before osteopontin can be considered a practical therapy.

References

Alam, M., Bertolini, M., Gherardini, J., et al. (2020). An osteopontin-derived peptide inhibits human hair growth at least in part by decreasing fibroblast growth factor-7 production in outer root sheath keratinocytes. British Journal of Dermatology, 182(6), 1404–1414. PMID: 31487385. https://pubmed.ncbi.nlm.nih.gov/31487385/

Follicum AB. (2021, May 6). Follicum reports top-line results from Phase IIa study of FOL-005 for treatment of hair loss (alopecia) [Press release]. https://news.cision.com/follicum/r/follicum-reports-top-line-results-from-phase-iia-study-of-fol-005-for-treatment-of-hair-loss--alopec,c3341890

Kahles, F., Findeisen, H. M., & Bruemmer, D. (2014). Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes. Molecular Metabolism, 3(4), 384–393. PMID: 24944898. https://pubmed.ncbi.nlm.nih.gov/24944898/

Liaw, L., Birk, D. E., Ballas, C. B., Whitsitt, J. S., Davidson, J. M., & Hogan, B. L. (1998). Altered wound healing in mice lacking a functional osteopontin gene (spp1). Journal of Clinical Investigation, 101(7), 1468–1478. PMID: 9525990. https://pubmed.ncbi.nlm.nih.gov/9525990/

Sodek, J., Ganss, B., & McKee, M. D. (2000). Osteopontin. Critical Reviews in Oral Biology and Medicine, 11(3), 279–303. https://doi.org/10.1177/10454411000110030101

Reddit. (2024, January 20). Amplifica and AMP-303 clinical phase 1. Tressless community. https://reddit.com/r/tressless/comments/19bmy76/amplifica_and_amp303_clinical_phase_1/

Reddit. (2024, September 15). Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025. Tressless community. https://reddit.com/r/tressless/comments/1fh9yhi/coegin_pharma_to_release_follicopeptide_fol005_by/

Reddit. (2024, August 19). Found an interesting little article. Tressless community. https://reddit.com/r/tressless/comments/1evpvxi/found_an_interesting_little_article/

Reddit. (2024, August 6). Soundwaves & Electricity Grows Hair? | Peptide Delivery Model. Tressless community. https://reddit.com/r/tressless/comments/1elo36e/soundwaves_electricity_grows_hair_peptide/

Reddit. (2024, July 6). Peptides that Stop Hair Loss? | In-depth Literature Review Video. Tressless community. https://reddit.com/r/tressless/comments/1dwzqfs/peptides_that_stop_hair_loss_indepth_literature/

Reddit. (2025, September 1). IGF-1 and Peptides? Miracle molecule waiting to be found. Tressless community. https://reddit.com/r/tressless/comments/1n5jz0d/igf1_and_peptides_miracle_molecule_waiting_to_be/

Reddit. (2025, April 25). New Hair Loss Treatment: Adipose Derived Secretomes. Tressless community. https://reddit.com/r/tressless/comments/1k7mrwu/new_hair_loss_treatment_adipose_derived_secretomes/

Reddit. (2024, August 18). Forgotten Hair Loss Peptide by L'Oreal: KPV. Tressless community. https://reddit.com/r/tressless/comments/1evburr/forgotten_hair_loss_peptide_by_loreal_kpv/

Reddit. (2024, March 23). Expectations control for SCUBE3. Tressless community. https://reddit.com/r/tressless/comments/1blefzz/expectations_control_for_scube3/